Sanderling Venture Partners V, Lp - Net Worth and Insider Trading
Sanderling Venture Partners V, Lp Net Worth
The estimated net worth of Sanderling Venture Partners V, Lp is at least $86 Million dollars as of 2024-11-10. Sanderling Venture Partners V, Lp is the 10% Owner of Endocyte Inc and owns about 3,585,617 shares of Endocyte Inc (ECYT) stock worth over $86 Million. Sanderling Venture Partners V, Lp is also the 10% Owner of Chimerix Inc and owns about 112,674 shares of Chimerix Inc (CMRX) stock worth over $110,421. Details can be seen in Sanderling Venture Partners V, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sanderling Venture Partners V, Lp has not made any transactions after 2013-04-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sanderling Venture Partners V, Lp
Sanderling Venture Partners V, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sanderling Venture Partners V, Lp owns 2 companies in total, including Chimerix Inc (CMRX) , and Endocyte Inc (ECYT) .
Insider Ownership Summary of Sanderling Venture Partners V, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMRX | Chimerix Inc | 2013-04-10 | 10 percent owner |
| ECYT | Endocyte Inc | 2011-12-21 | 10 percent owner |
Sanderling Venture Partners V, Lp Latest Holdings Summary
Sanderling Venture Partners V, Lp currently owns a total of 2 stocks. Among these stocks, Sanderling Venture Partners V, Lp owns 3,585,617 shares of Endocyte Inc (ECYT) as of December 21, 2011, with a value of $86 Million and a weighting of 99.87%. Sanderling Venture Partners V, Lp also owns 112,674 shares of Chimerix Inc (CMRX) as of April 10, 2013, with a value of $110,421 and a weighting of 0.13%.
Latest Holdings of Sanderling Venture Partners V, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ECYT | Endocyte Inc | 2011-12-21 | 3,585,617 | 23.99 | 86,018,952 |
| CMRX | Chimerix Inc | 2013-04-10 | 112,674 | 0.98 | 110,421 |
Holding Weightings of Sanderling Venture Partners V, Lp
Sanderling Venture Partners V, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Sanderling Venture Partners V, Lp has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the acquisition of 435,600 shares on December 21, 2011, which cost Sanderling Venture Partners V, Lp around $1 Million.
According to the SEC Form 4 filings, Sanderling Venture Partners V, Lp has made a total of 0 transactions in Chimerix Inc (CMRX) over the past 5 years. The most-recent trade in Chimerix Inc is the sale of 0 shares on April 10, 2013, which brought Sanderling Venture Partners V, Lp around $0.
Insider Trading History of Sanderling Venture Partners V, Lp
- 1
Sanderling Venture Partners V, Lp Trading Performance
GuruFocus tracks the stock performance after each of Sanderling Venture Partners V, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sanderling Venture Partners V, Lp is 68.05%. GuruFocus also compares Sanderling Venture Partners V, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sanderling Venture Partners V, Lp within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sanderling Venture Partners V, Lp's insider trading performs compared to the benchmark.
Performance of Sanderling Venture Partners V, Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.18 | | | | | |
| Relative Return to S&P 500(%) | 5.42 | | | | | |
Sanderling Venture Partners V, Lp Ownership Network
Ownership Network List of Sanderling Venture Partners V, Lp
Ownership Network Relation of Sanderling Venture Partners V, Lp
Sanderling Venture Partners V, Lp Owned Company Details
What does Chimerix Inc do?
Who are the key executives at Chimerix Inc?
Sanderling Venture Partners V, Lp is the 10 percent owner of Chimerix Inc. Other key executives at Chimerix Inc include Chief Business Officer Michael T. Andriole , Principal Accounting Officer David Jakeman , and director & Chief Executive Officer Michael A. Sherman .
Chimerix Inc (CMRX) Insider Trades Summary
Over the past 18 months, Sanderling Venture Partners V, Lp made no insider transaction in Chimerix Inc (CMRX). Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 40,000 shares made by Fred A Middleton , a net sale of 6,270 shares made by David Jakeman , and a net sale of 3,029 shares made by Michael T. Andriole .
In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,239 shares of Chimerix Inc (CMRX) were sold and 127,000 shares were bought by its insiders, resulting in a net purchase of 115,761 shares.
Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chimerix Inc Insider Transactions
Sanderling Venture Partners V, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Sanderling Venture Partners V, Lp. You might contact Sanderling Venture Partners V, Lp via mailing address: 400 South El Camino Real, Suite 1200, San Mateo Ca 94402.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
